Nanchang University First Affiliated Hospital Completes First Gynecological Clinical Trial of Tuoling® Laparoscopic Surgical Robot

Domestic laparoscopic surgical robots achieve another major breakthrough! Recently,Professor Cai Liping, Director of the Department of Obstetrics and Gynecology at the First Affiliated Hospital of Nanchang University (hereinafter referred to as “the First Affiliated Hospital of Nanchang University”), led her team in successfully conducting the first gynecological clinical trial of the Tuoling® laparoscopic surgical robot.. Developed independently by Tuodao Medical, a domestic leader in innovative surgical robotics, the product assisted Professor Cai Liping’s team in successfully completing a highly complex radical hysterectomy.

It is reported that the patient undergoing this surgery was a 56-year-old woman diagnosed with stage IIA cervical cancer. Her condition was particularly complex, having received two cycles of neoadjuvant chemotherapy prior to surgery, which significantly increased the surgical difficulty. Drawing on years of clinical experience and expertise in robotic surgery, Professor Cai Liping’s team decided to employ the Tuoling^®Laparoscopic surgical robots are employed to perform radical hysterectomy, thereby maximizing patient safety.

However, during the surgery, Professor Cai Liping discovered extensive and dense adhesions in the patient’s pelvic cavity, making the procedure far more complex and technically challenging than anticipated. Nevertheless, thanks to the precise and error-free manipulation, stable and reliable performance, and high-definition visual system of the robotic laparoscopic surgical system, the operation proceeded in an orderly manner.

Under the operation of Professor Cai Liping, the laparoscopic surgical robot skillfully exposed the medial aspect of the uterosacral ligament, subsequently dissected the ureter, and then separated the lateral aspect of the uterosacral ligament with high precision, further dissecting the paravesical space. After completing these critical steps, the robot opened the ureteral tunnel and meticulously managed the paravaginal tissue. Finally, the robot accurately transected the vagina and completed the suturing.

Severe pelvic adhesions; clear dissection of the iliac vessels

Following the procedure, Professor Cai Liping stated, “We successfully performed a radical hysterectomy, pelvic lymphadenectomy, and para-aortic lymphadenectomy—a surgical intervention that was both extensive and complex. In this significant challenge, our domestically produced laparoscopic surgical robot once again demonstrated its superior performance by flawlessly executing the surgical tasks. It will undoubtedly lead gynecological surgery into a new era of domestic surgical robots characterized by minimally invasive techniques, precision, and intelligence.”

Professor | Chief Physician | Doctoral Supervisor

Recipient of numerous honors, including Academic Leader by the Jiangxi Provincial Health Department, First Young Scientist of Jiangxi Province, Academic Leader for Young and Middle-aged Faculty in Jiangxi Universities, Academic Leader in the Jiangxi Health System, and Advanced Individual in Jiangxi Health Science and Technology Work. Awarded the Third Prize for Scientific and Technological Progress by the Provincial Department of Science and Technology twice. Pioneered the implementation of high-difficulty procedures across Jiangxi Province, such as laparoscopic radical hysterectomy with pelvic lymphadenectomy for gynecologic malignancies. Currently performs the highest volume of complex da Vinci robotic surgeries in Jiangxi Province, having completed over 1,500 da Vinci robotic procedures to date.

Tuoling^®Endoscopic surgical robots consist of a surgeon console, a patient-side surgical platform, and an image processing platform. Compared with traditional endoscopy, Tuoling^®The 8-degree-of-freedom control arms of the laparoscopic surgical robot provide surgeons with an exceptionally dexterous operational experience. The proprietary 3D electronic endoscope delivers stereoscopic images with rich depth-of-field information, offering surgeons meticulous, immersive visual feedback. High-precision master-slave control algorithms enable surgeons to perform delicate maneuvers with ease, facilitating minimally invasive and precise lesion resection. Intelligent human-machine interaction design simplifies user operations through automated features such as one-click positioning, thereby enhancing surgical efficiency. A comprehensive suite of 15 types of instruments meets the routine clinical and customized needs across various medical departments.

Tuodao Medical specializes in the design, R&D, and clinical implementation of surgical robots, dedicated to providing robotic solutions for medical users across all specialties, thereby empowering the development of the smart healthcare industry through technological innovation.

Leveraging cutting-edge core technologies such as data algorithms, artificial intelligence, and precision intelligent control, Tuodao Medical has meticulously developed a core technology platform for surgical robots. The company has strategically laid out its presence in five major surgical robot sectors: orthopedics, endoscopy, percutaneous puncture, natural orifice transluminal surgery, and medical imaging equipment. By deeply cultivating diverse clinical departments and procedural applications, Tuodao Medical’s surgical robot product pipeline now covers orthopedics, general surgery, gynecology, urology, pulmonology, radiology, and other specialties.

Looking ahead, guided by its corporate mission to “make surgery simpler and life healthier,” Tuodao Medical will collaborate with industry and ecosystem partners to establish a comprehensive product portfolio across all medical specialties, build an integrated remote smart healthcare center, and jointly shape the future of human health.

In 2022, Tuodao Medical's TuoHand^®Orthopedic surgical robots and Daoying mobile C-arm X-ray machines have been approved for market launch; in 2023, Daoying 3D mobile C-arm X-ray machines and Tuoying^®Mobile C-arm X-ray Machine and Tuodao Surgery^®Percutaneous Puncture Surgical Robot Obtains Certification and Achieves Commercialization. In 2024, the Core Product Tuoling^®Laparoscopic surgical robots have officially entered human clinical trials. We believe that AI-empowered healthcare will benefit a vast number of patients and promote healthier lives.